⌘K

Home/Filings/4/0001104659-21-086988

4//SEC Filing

Freeman Roy Lester 4

Accession 0001104659-21-086988

CIK 0001750149other

View on SEC.gov Company Profile

Filed

Jun 28, 8:00 PM ET

Accepted

Jun 29, 7:10 PM ET

Size

5.1 KB

Accession

0001104659-21-086988

Insider Transaction Report

Form 4

Period: 2021-06-25

Inhibikase Therapeutics, Inc.IKT

Freeman Roy Lester

Director

Transactions

Award
Stock Option (right to buy)
2021-06-25+22,677→ 22,677 total
Exercise: $2.92From: 2022-06-25Exp: 2028-06-25→ Common Stock (22,677 underlying)

Documents

1 file

4
tm2120992d2_4.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

Inhibikase Therapeutics, Inc.

CIK 0001750149

Entity typeother

Related Parties

1

filerCIK 0001799732

Filing Metadata

Form type: 4
Filed: Jun 28, 8:00 PM ET
Accepted: Jun 29, 7:10 PM ET
Size: 5.1 KB

View on SEC.gov